ANT-SM (Anterogen)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameANT-SM (Anterogen)

Drug Alias NameAutologous Cultured Adipose-Derived Stem Cells for the Fecal Incontinenceautologous adipose-derived stem cell (Anterogen)Autologous Cultured Adipose-derived Stem Cell (Anterogen)ANT-SM

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsFistulaFecal IncontinenceRectal Fistula

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesAnterogen Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAnterogen Co Ltd

Inactive CompaniesN/A

Active IndicationsFistula

Inactive IndicationsFecal IncontinenceRectal Fistula

Other Information

ATC CodeN/A